Premium
Risks of inhibitors from recombinant factor VIII : a quarter of a century to reach the conclusion
Author(s) -
Burnouf T.,
Strengers P. F. W.
Publication year - 2016
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.13435
Subject(s) - medicine , von willebrand factor , adverse effect , recombinant dna , coagulopathy , clinical trial , randomized controlled trial , antibody , antithrombin , immunology , heparin , biochemistry , platelet , chemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom